Bayer lawsuit: Plaintiff witness rejects EPA Roundup safety assessment as next glyphosate-cancer trial begins

portier
Bio-statisticianChristopher Portier testified in latest glyphosate-cancer trial on April 2, 2019

At the start of testimony in what looks to be a long and contentious trial over whether [Bayer’s herbicide] Roundup caused the cancer of an elderly couple, a cancer-risk expert said he would give the U.S. Environmental Protection Agency an “F” on its report deeming glyphosate, one of the main agrochemicals in Roundup, noncarcinogenic.

“I’d fail them,” Dr. Christopher Portier testified.

[Editor’s note: Read GLP’s FAQ Is glyphosate (Roundup) dangerous? to learn more.]

The bio-statistician challenged the EPA’s glyphosate issue paper from 2016 because, among other issues, it failed to disclose that one of the studies it used had been invalidated due to scientific fraud.

The study, conducted in 1973 by the now-defunct Industrial Bio-Test (IBT) Laboratories, found no statistically significant increase in tumors in albino mice after 18 months of feeding them glyphosate. That study was invalidated by the EPA itself after IBT was caught in an audit having falsified its data.

Read full, original article: Expert Flunks EPA Handling of Roundup Approval

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}
skin microbiome x final

Infographic: Could gut bacteria help us diagnose and treat diseases? This is on the horizon thanks to CRISPR gene editing

Humans are never alone. Even in a room devoid of other people, they are always in the company of billions ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.